ONXX Financial Facts
Total revenue: 153.03MInterest expense: -5.71M
See Full Income Statement
Other assets: 7.03M
Intangible assets - in-process research and development: 171.5M
See Full Balance Sheet
Onyx Pharmaceuticals Inc. (ONXX) Earnings
|
Expand Research on ONXX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +32.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/22/12  |
 |
Q411 | $1.50 | $1.43 | +$0.07 | $237M | $213.24M | N/A |  | | Details |
| 8/8/13 |
|
Q213 | -$0.40 | -$0.42 | +$0.02 | $153M | $151.73M | N/A | | | Details |
| 5/7/13 |
|
Q113 | -$0.19 | -$0.47 | +$0.28 | $145.5M | $134.36M | N/A | | | Details |
| 2/21/13 |
|
Q412 | -$0.36 | -$0.75 | +$0.39 | $127.9M | $113.17M | N/A | | | Details |
| 11/1/12 |
|
Q312 | -$0.79 | -$0.90 | +$0.11 | $89.51M | $80.02M | N/A | | | Details |
| 11/2/11 |
|
Q311 | -$0.31 | -$0.19 | -$0.12 | $75.04M | $80.38M | N/A | | | Details |
| 8/1/12 |
Q212 | -$0.68 | -$0.66 | -$0.02 | $72.7M | $72.07M | N/A | | | Details | |
| 5/2/12 |
|
Q112 | -$0.68 | -$0.55 | -$0.13 | $72M | $69.82M | N/A | | | Details |
